Immunodeficiency Cure Found in Bone Marrow Transplants

Manipal Hospital Yelahanka recently concluded the Manipal Immuno Transplant Summit, a two-day academic forum dedicated to primary immunodeficiencies and bone marrow transplantation (BMT). The event, held on April 25-26, 2026, brought together over 15 national experts and international faculty, attracting more than 200 delegates from across India. The summit uniquely merged the fields of immunodeficiency and BMT, traditionally treated separately, fostering a multidisciplinary dialogue among various medical specialties.

Dr. Sagar Bhattad, the organizing secretary, highlighted the summit's significance in addressing underdiagnosed immunodeficiencies, stating it's the first time these conditions and their BMT cure were presented together. He noted the advancements in molecular genetics aid in identifying transplant candidates. International experts like Dr. Janet Markle and Prof. Dr. Andrew Gennery shared crucial insights on genetic diagnostics and the specialized nature of BMT for immune disorders, emphasizing its potential for a complete cure.

The forum also featured reflections from senior Indian experts on the evolution of immunodeficiency management. Scientific sessions covered diagnostic challenges, transplant strategies, and manifestations across organ systems. Manipal Hospital Yelahanka's specialized expertise in immunology and BMT for immune disorders, recognized as a Center of Excellence, was also a key highlight. The summit aimed to shift clinical perspectives towards a unified, diagnosis-driven approach for better patient outcomes.